Jinling Pharmaceutical Co Ltd (000919) — Capital Reinvestment Ratio
Jinling Pharmaceutical Co Ltd (000919) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥74.01 Million) in capital expenditures (CN¥12.56 Million). Check Jinling Pharmaceutical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jinling Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2024)
This chart tracks Jinling Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods. For the full cash flow conversion analysis, see 000919 operating cash flow.
Annual Capital Reinvestment Ratio for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year Capital Reinvestment Ratio for Jinling Pharmaceutical Co Ltd from 1999 to 2024. See 000919 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.31x | CN¥154.19 Million | CN¥201.63 Million | ▲ +11.6% |
| 2023 | 1.17x | CN¥158.92 Million | CN¥186.25 Million | ▼ -1.4% |
| 2022 | 1.19x | CN¥260.59 Million | CN¥309.64 Million | ▲ +113.2% |
| 2021 | 0.56x | CN¥292.03 Million | CN¥162.76 Million | ▼ -40.4% |
| 2020 | 0.94x | CN¥311.46 Million | CN¥291.41 Million | ▲ +246.7% |
| 2019 | 0.27x | CN¥465.85 Million | CN¥125.71 Million | ▼ -14.2% |
| 2018 | 0.31x | CN¥433.83 Million | CN¥136.42 Million | ▲ +108.6% |
| 2017 | 0.15x | CN¥443.11 Million | CN¥66.80 Million | ▼ -86.5% |
| 2016 | 1.12x | CN¥96.15 Million | CN¥107.45 Million | ▲ +127.6% |
| 2015 | 0.49x | CN¥212.45 Million | CN¥104.31 Million | ▲ +61.6% |
| 2014 | 0.30x | CN¥299.89 Million | CN¥91.14 Million | ▼ -42.8% |
| 2013 | 0.53x | CN¥271.21 Million | CN¥144.05 Million | ▼ -34.7% |
| 2012 | 0.81x | CN¥232.12 Million | CN¥188.76 Million | ▲ +71.0% |
| 2011 | 0.48x | CN¥172.82 Million | CN¥82.20 Million | ▼ -11.4% |
| 2010 | 0.54x | CN¥177.81 Million | CN¥95.48 Million | ▲ +4.7% |
| 2009 | 0.51x | CN¥188.41 Million | CN¥96.60 Million | ▲ +607.8% |
| 2008 | 0.07x | CN¥305.26 Million | CN¥22.11 Million | ▼ -59.2% |
| 2007 | 0.18x | CN¥118.06 Million | CN¥20.97 Million | ▲ +6.5% |
| 2006 | 0.17x | CN¥138.50 Million | CN¥23.09 Million | ▼ -50.2% |
| 2005 | 0.33x | CN¥109.29 Million | CN¥36.61 Million | ▼ -26.1% |
| 2004 | 0.45x | CN¥159.81 Million | CN¥72.47 Million | ▲ +29.4% |
| 2003 | 0.35x | CN¥161.86 Million | CN¥56.73 Million | ▼ -55.5% |
| 2002 | 0.79x | CN¥130.36 Million | CN¥102.63 Million | ▼ -54.6% |
| 2001 | 1.73x | CN¥92.49 Million | CN¥160.27 Million | ▲ +198.0% |
| 2000 | 0.58x | CN¥231.31 Million | CN¥134.49 Million | ▼ -67.7% |
| 1999 | 1.80x | CN¥39.77 Million | CN¥71.57 Million | — |